CN105777729A - Coumarin amides compound as well as preparation method and application of coumarin amides compound - Google Patents

Coumarin amides compound as well as preparation method and application of coumarin amides compound Download PDF

Info

Publication number
CN105777729A
CN105777729A CN201610178931.XA CN201610178931A CN105777729A CN 105777729 A CN105777729 A CN 105777729A CN 201610178931 A CN201610178931 A CN 201610178931A CN 105777729 A CN105777729 A CN 105777729A
Authority
CN
China
Prior art keywords
compound
diarbarone
benzothiazole
benzopyran
carbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610178931.XA
Other languages
Chinese (zh)
Inventor
贾建洪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University of Technology ZJUT
Original Assignee
Zhejiang University of Technology ZJUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University of Technology ZJUT filed Critical Zhejiang University of Technology ZJUT
Priority to CN201610178931.XA priority Critical patent/CN105777729A/en
Publication of CN105777729A publication Critical patent/CN105777729A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00Other synthetic dyes of known constitution
    • C09B57/02Coumarine dyes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D7/00Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
    • C09D7/40Additives
    • C09D7/41Organic pigments; Organic dyes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1033Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention relates to the field of compound synthesis and in particular relates to a coumarin amides compound as well as a preparation method and application of the coumarin amides compound. The structural formula of the coumarin amides compound is shown as the description, wherein an R radical is phenyl, substituted phenyl or pyridyl. The coumarin amides compound is synthesized by taking acylamino as a bridge group, and has the advantages of convenience for synthesis, moderate reaction conditions and stable product structure; the finally obtained target compound has a relatively strong intramolecular conjugated electron transfer effect, a relatively high molar light absorption coefficient and relatively large Strokes displacement.

Description

A kind of Diarbarone compounds and its preparation method and application
Technical field
The present invention relates to compou nd synthesis field, more particularly to a kind of Diarbarone compounds and its preparation method and application.
Background technology
Coumarin and derivant thereof are the organic heterocyclic molecules that a class is important, all contain similar structures, and have multiple biological activity in many natural and synthetic drug molecules.Coumarin and derivant thereof are as the electron transporting compound of conjugation in molecule, there is excellent fluorescence quantum efficiency, high molar absorption coefficient and big Stokes displacement, it is widely used in the high-technology fields such as coloring plastic, color fluorescence coating, the color fluorescence resin of solar collector, sensitive material, light-sensitive material, video disc recording material, it have been reported that coumarin nicotinamide compounds, it is applied mainly as metal ion probe and biostatic agent, its performance in optics of less research.
This kind of coumarin compound with fluorescence is generally made up of three parts: coumarin ring (pi-electron donor), pi-electron bridged group (abbreviation abutment), pi-electron receptor (or donor), pi-electron abutment is generally carbon-carbon double bond (C=C), carbon-to-nitrogen double bon (C=N), and less employing amide groups (CONH) makes abutment.
Summary of the invention
It is an object of the invention to solve the deficiencies in the prior art, it is provided that a kind of be abutment with amide groups Diarbarone compounds and its preparation method and application.
The technical solution adopted for the present invention to solve the technical problems is:
A kind of Diarbarone compounds, its structural formula is as follows:
Described R group is phenyl, substituted-phenyl or pyridine radicals.
Preferably, described substituent group is selected from any one in substituents:
A kind of preparation method of Diarbarone compounds, described preparation method carries out as follows:
(1) with salicylide, cyan-acetic ester, 3,4-AHBA for raw material, one pot process 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-carboxylic acid;
(2) 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-carboxylic acid that above-mentioned steps is synthetically derived and chloride reagent carry out acyl chloride reaction and are synthetically derived 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-formyl chloride;
(3) 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-formyl chloride that above-mentioned steps obtains reacts with amino-compound and carries out acylation reaction, is synthetically derived Diarbarone compounds.
Preferably, described chloride reagent is oxalyl chloride, thionyl chloride or triphosgene, and described amino-compound is aniline, replacement, aniline or aminopyridine.
More having choosing, described amino-compound is any one in following amino-compound:
Preferably, described preparation method is specific as follows:
(1) in 100mL there-necked flask, salicylide 17mmol, cyan-acetic ester 17mmol, 3,4-AHBA 17mmol, benzoic acid 5.8mmol and n-amyl alcohol 50mL it are sequentially added into, it is heated to reflux 5-12h, it is cooled to room temperature, reactant liquor is poured in 100mL water, precipitate out a large amount of precipitation, sucking filtration, washes with water dried, obtains orange solids 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-carboxylic acid;
(2) in 50mL there-necked flask, 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-carboxylic acid 1mmol and solvent 30mL is added, chloride reagent 1.2mmol is dripped under room temperature, add DMF1 and drip as catalyst, solvent and residue chloride reagent are evaporated off after reacting 2-10h at 20-120 DEG C, obtaining khaki solid 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-formyl chloride, described solvent is dichloromethane or toluene;
(3) in 100mL there-necked flask, it is sequentially added into amino-compound 1mmol, Na2CO31.1mmol and anhydrous CH2Cl220mL, is cooled to 0~5 DEG C, drips 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-formyl chloride 1mmol and anhydrous CH2Cl2The mixed liquor of 30mL, after reacting 3-106h in-5~10 DEG C, reacts 5-20h, filters under room temperature, filtrate adds saturated NaHCO3Solution 25mL, stratification, the anhydrous CH of water layer2Cl2Extracting, merge organic facies, solvent is evaporated off, column chromatography purifies, and the volume ratio=4:1 of developing solvent petroleum ether and ethyl acetate obtains Diarbarone compounds.
The application of a kind of Diarbarone compounds, as fluorescent pigment application in coating.
The invention has the beneficial effects as follows: the present invention is using amide groups as abutment synthesizing coumarin amides compound, there is the advantage that synthesis is convenient, reaction condition is gentle and product structure is stable, and the target compound finally given has a conjugated electrons transfer effect in stronger molecule, and higher molar absorption coefficient and relatively larger Stokes displacement.
Accompanying drawing explanation
Fig. 1 is target compound uv-visible absorption spectra in dichloromethane;
Fig. 2 is target compound fluorescence emission spectrum in dichloromethane;
Fig. 3 is compound 1a uv-visible absorption spectra in different solvents;
Fig. 4 is compound 1a fluorescence emission spectrum in different solvents;
Fig. 5 is compound 1a fluorescence in different solvents;
In Fig. 5, solvent is followed successively by toluene, dichloromethane, THF, DMF, methanol from left to right.
Detailed description of the invention
Below by specific embodiment, and in conjunction with accompanying drawing, technical scheme is described in further detail.
Embodiment 1:
1.1 reagent and instrument
Instrument: Bruker-500MHz nuclear magnetic resonance spectrometer (AVANCE III type, Bruker company of Germany);nullShimadzu ultraviolet-visible spectrophotometer (UV-2550 type,Measurement scope: 190-1100nm,Certainty of measurement: 0.01,Shimadzu Corporation of Japan),Hitachi spectrofluorophotometer instrument (F-2500 type,Wave-length coverage: 220-730nm,HIT),ThermoFinniganLCQSeries,Agilent6210SeriesTime-of-Flight mass spectrograph (ESI/APCI) (LCQDECAXPPLUS type,Agilent company of the U.S.),(wave number sweep limits is 350-4000cm-1 to Nicolet6700 Fourier transformation infrared spectrometer,KBr pressed disc method,U.S. thermoelectricity Buddhist nun high-tensile strength company).
Reagent: cyan-acetic ester (AR, Chemical Reagent Co., Ltd., Sinopharm Group);Salicylide, 3,4-AHBA, oxalyl chloride and substituted aromatic amines etc. (AR, Aladdin biotech inc, Shanghai).
1.2 synthetic routes and method
With salicylide, cyan-acetic ester, 3,4-AHBA for raw material; one pot process 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-carboxylic acid (I); it is synthesized then through chloride and N-acidylate etc. and obtains 8 target compounds, synthesize as follows in line:
(1) synthesis of 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-carboxylic acid (I):
It is sequentially added into salicylide (2.076g in 100mL there-necked flask, 17mmol), cyan-acetic ester (7.923g, 17mmol), 3,4-AHBA (2.603g, 17mmol), benzoic acid (0.71g, 5.8mmol) with n-amyl alcohol (50mL), it is heated to reflux 12h, it is cooled to room temperature, reactant liquor is poured in water (100mL), precipitate out a large amount of precipitation, sucking filtration, dried with water (3 × 20mL) washing, obtaining orange solids 3.41g, yield is 65.34%1HNMR (500MHz, DMSO-d6) δ 9.12 (s, 1H, C=CH), 8.35 (s, 1H, Ar-H), 8.10~8.08 (d, 1H, Ar-H), 8.03~8.02 (d, 1H, Ar-H), 7.93~7.91 (d, 1H, Ar-H), 7.80~7.77 (t, 1H, Ar-H), 7.52~7.45 (m, 2H, Ar-H);
(2) synthesis of 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-formyl chloride (II):
Compound (I) (0.307g, 1mmol) and anhydrous CH is added in 50mL there-necked flask2Cl2(30mL), under room temperature, drip oxalyl chloride (0.125g, 1.2mmol), add DMF (1) as catalyst, solvent and residue oxalyl chloride are evaporated off after reacting 2h at 20 DEG C, obtain khaki solid 0.305g, yield 93.8%;
(3) synthesis of compound 1a-1h:
Substituted aromatic amines (1mmol), Na it is sequentially added in 100mL there-necked flask2CO3(0.117g, 1.1mmol) and anhydrous CH2Cl2(20mL), it is cooled to 0~5 DEG C, drips compound (II) (0.325g, 1mmol) and anhydrous CH2Cl2(30mL) mixed liquor, after reacting 6h in 0~5 DEG C, reacts 16h, filters at 20 DEG C, filtrate adds saturated NaHCO3Solution (25mL), stratification, the anhydrous CH of water layer2Cl2(3 × 25mL) extracts, and merges organic facies, solvent is evaporated off, and column chromatography purifies, and developing solvent V (petroleum ether): V (ethyl acetate)=4:1 obtains compound 1a-1h, shown in result table 1:
The synthesis of table 1 compound 1a-1h
1.3 target compounds characterize
Compound 1a:IR (KBr, υ/cm-1):3380,3051,2924,1723,1666,1608,1537,1498,1437,1320,1265,1238,1187,1157,1119,1009,900,850,751,687.1HNMR(500MHz,DMSO-d6) δ 10.40 (s, 1H, CO-NH), 9.13 (s, 1H, C=CH), 8.47~8.46 (d, 1H, Ar-H), 8.11~8.09 (dd, 1H, Ar-H), 8.05~8.03 (dd, 1H, Ar-H), 7.98~7.97 (d, 1H, Ar-H), 7.82~7.80 (d, 1H, Ar-H), 7.78~7.76 (m, 2H, Ar-H), 7.53~7.52 (d, 1H, Ar-H), 7.49~7.48 (m, 1H, Ar-H), 7.40~7.37 (t, 2H, Ar-H), 7.15~7.13 (d, 1H, Ar-H);HR-ESI/MS(m/z)calcdforC23H15N2O4[M+H]+=383.1026, found383.1019.
Compound 1b:IR (KBr, υ/cm-1):3218,3048,2921,2851,1751,1635,1605,1524,1452,1390,1310,1255,1195,1119,968,921,753,685.1HNMR(500MHz,CDCl3) δ 8.85 (s, 1H, C=CH), 8.36 (s, 1H, CO-NH), 8.08~8.03 (m, 2H, Ar-H), 7.78~7.70 (m, 4H, Ar-H), 7.47~7.41 (m, 2H, Ar-H), 7.32~7.30 (d, 1H, Ar-H), 7.28~7.26 (d, 1H, Ar-H), 7.17~7.14 (m, 1H, Ar-H), 2.39 (s, 3H, CH3);HR-ESI/MS(m/z)calcdforC24H17N2O4[M+H]+=397.1183, found397.1187.
Compound 1c:IR (KBr, υ/cm-1):3274,3094,1742,1646,1611,1527,1440,1314,1250,1182,1066,1002,831,761,645.1HNMR(500MHz,DMSO-d6) δ 10.23 (s, 1H, CO-NH), 9.12 (s, 1H, C=CH), 8.48~8.47 (d, 1H, Ar-H), 8.13~8.12 (dd, 1H, Ar-H), 8.03~8.01 (dd, 1H, Ar-H), 7.98~7.96 (d, 1H, Ar-H), 7.79~7.76 (m, 1H, Ar-H), 7.65~7.64 (dd, 1H, Ar-H), 7.60~7.58 (dd, 1H, Ar-H), 7.52~7.50 (d, 1H, Ar-H), 7.48~7.41 (m, 2H, Ar-H), 7.35~7.32 (m, 1H, Ar-H);HR-ESI/MS(m/z)calcdforC23H14ClN2O4[M+H]+=417.0637, found417.0651.
Compound 1d:IR (KBr, υ/cm-1):3365,3101,2924,2850,1742,1694,1610,1541,1508,1465,1342,1264,1185,1124,1094,1031,999,963,912,863,800,756,691.1HNMR(500MHz,CDCl3) δ 8.89 (s, 1H, CO-NH), 8.86 (s, 1H, C=CH), 8.80~8.78 (d, 1H, Ar-H), 8.41~8.40 (d, 1H, Ar-H), 8.12 ,~8.10 (dd, 1H, Ar-H), 8.03~8.01 (dd, 1H, Ar-H), 7.85~7.84 (d, 1H, Ar-H), 7.80~7.79 (d, 1H, Ar-H), 7.75,~7.71 (m, 1H, Ar-H), 7.49~7.42 (m, 2H, Ar-H), 4.11 (s, 3H, OCH3);HR-ESI/MS(m/z)calcdforC24H15N3NaO7[M+Na]+=480.0802, found480.0793.
Compound 1e:IR (KBr, υ/cm-1):3355,3061,1745,1688,1614,1585,1517,1453,1383,1276,1221,1124,960,828,757.1HNMR(500MHz,CDCl3) δ 11.35 (s, 1H, CO-NH), 8.90 (s, 1H, C=CH), 8.89~8.88 (d, 1H, Ar-H), 8.52~8.51 (d, 1H, Ar-H), 8.13~8.11 (m, 2H, Ar-H), 7.81~7.79 (d, 1H, Ar-H), 7.75~7.70 (m, 2H, Ar-H), 7.58~7.56 (dd, 1H, Ar-H), 7.48~7.46 (d, 1H, Ar-H), 7.44~7.41 (d, 1H, Ar-H), 2.45 (s, 3H, CH3);HR-ESI/MS(m/z)calcdforC24H16N3O6[M+H]+=442.1034, found442.1046.
Compound 1f:IR (KBr, υ/cm-1):3360,1758,1700,1608,1553,1501,1420,1337,1282,1170,1121,1090,960,831,764,735,664.1HNMR(500MHz,DMSO-d6) δ 10.90 (s, 1H, CO-NH), 9.16 (s, 1H, C=CH), 8.46~8.45 (d, 1H, Ar-H), 8.11~8.09 (dd, 1H, Ar-H), 8.07~8.02 (m, 3H, Ar-H), 7.84~7.78 (m, 3H, Ar-H), 7.54~7.53 (d, 1H, Ar-H), 7.50~7.45 (m, 2H, Ar-H);HR-ESI/MS(m/z)calcdforC23H14N3O6[M+H]+=428.0877, found428.0866.
Compound 1g:IR (KBr, υ/cm-1):3375,3095,2924,2851,2754,1748,1688,1608,1566,1495,1433,1290,1244,1180,1155,1096,1042,991,960,881,829,756,689.1HNMR(500MHz,CDCl3) δ 10.25 (s, 1H, CO-NH), 8.88 (s, 1H, C=CH), 8.77~8.76 (d, 1H, Ar-H), 8.37~8.35 (dd, 1H, Ar-H), 8.00~7.98 (dd, 1H, Ar-H), 7.81~7.79 (d, 1H, Ar-H), 7.75~7.72 (t, 3H, Ar-H), 7.50~7.46 (m, 2H, Ar-H), 7.43~7.39 (m, 2H, Ar-H);HR-ESI/MS(m/z)calcdforC22H14N3O4[M+H]+=384.0979, found384.0972.
Compound 1h:IR (KBr, υ/cm-1):3384,3062,2930,2835,1728,1667,1609,1539,1483,1448,1269,1218,1152,1121,1049,1006,962,926,880,844,755,687,640.1HNMR(500MHz,CDCl3) δ 8.85 (s, 1H, C=CH), 8.34 (s, 1H, CO-NH), 8.02~8.00 (d, 1H, Ar-H), 7.91 (s, 1H, Ar-H), 7.76~7.70 (m, 3H, Ar-H), 7.47~7.41 (m, 3H, Ar-H), 7.32~7.30 (d, 1H, Ar-H), 7.15~7.13 (d, 1H, Ar-H), 6.76~6.74 (d, 1H, Ar-H), 3.87 (s, 3H, OCH3);HR-ESI/MS(m/z)calcdforC24H17N2O5[M+H]+=413.1132, found413.1118.
1.4 target compounds spectrum property in dichloromethane
(concentration of 1a, 1c, 1d, 1e is 1 × 10 as shown in Fig. 1 and table 2 to test 8 compounds uv-visible absorption spectra in dichloromethane solution and fluorescence spectrum, its maximum absorption wavelength (λ max) and maximum emission wavelength (λ em)-5Mol/L, 1b, 1g, 1h concentration be 2 × 10-5The concentration of mol/L, 1f is 2.2 × 10-5mol/L)。
The table 2 spectroscopic data in dichloromethane
From Fig. 1 and Biao 2 it can be seen that the ultraviolet spectra of target compound all presents two obvious maximum absorption bands, that occur in 250nm place is π → π*The absworption peak that electron transition produces;The absworption peak occurring in about 350nm then comes from Intramolecular electron transfer (ICT) absorption.Excitation wavelength is 350nm, and maximum emission wavelength λ em is about 90nm in about 440nm, Stokes displacement;Stokes displacement with the Coumarins fluorescent material reported is close, it depends primarily on N-phenyl-2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) this parent framework of benzothiazole-5-Methanamide, when the ortho position of substituted aromatic amines amino is with strong electron-withdrawing group group (1e, time 1f), maximum absorption wavelength and the emission maximum of corresponding compound have a little red shift and have bigger molar absorption coefficient, because the strong electron-withdrawing group group of end is conducive to the Intramolecular electron transfer of compound.The molar absorption coefficient of the coumarin kind compound being abutment with thiophene in prior art is 4.5 × 104M-1·cm-1;The target compound molar absorption coefficient at maximum absorption wavelength λ max place has reached 105M-1·cm-1The order of magnitude, it was shown that light is had good absorbability by it at maximum absorption wavelength λ max place, it is possible to become optical material.
Test compound 1a uv-visible absorption spectra in different solvents and fluorescence spectrum, its maximum absorption wavelength (λ max) and maximum emission wavelength (λ em) are as shown in Fig. 2 and table 3, and its fluorescence photo in different solvents is as shown in Figure 3.
Table 3 compound 1a spectroscopic data in opposed polarity solvent
As can be known from Fig. 2, the ultra-violet absorption spectrum of compound 1a and fluorescence emission spectrum change not quite in different solvents, and increasing with solvent polarity has a little red shift.Being likely due under ground state, in compound molecule, electric charge transfer is more weak, and its ultra-violet absorption spectrum is the not significant change with solvent polarity change just.
As can be seen from Figure 3, compound 1a fluorescence in middle low polar solvent (toluene, dichloromethane) is more apparent, and after solvent polarity increases, fluorescence substantially disappears.Being probably in DMF and methanol, the hydrogen bond action of solvent and compound can affect stablizing of ground state and excited state, causes that fluorescence disappears.
In sum, 8 new Diarbarone compounds of present invention synthesis, yield 41%~65%, its structure warp1HNMR, MS and IR characterize confirmation, determine uv-visible absorption spectra and the fluorescence spectrum of target compound, it has been found that its π-π * transition characteristics peak is between 250nm~255nm;Its maximum absorption wavelength is between 345nm~360nm;Maximum emission wavelength λ em is about 90nm in about 440nm, Stokes displacement;Its molar absorption coefficient has reached 105M-1·cm-1The order of magnitude, when there is electron withdraw group at the ortho position of substituted aromatic amines amino, the maximum absorption wavelength of compound and emission maximum have a little red shift and have bigger molar absorption coefficient.Its ultra-violet absorption spectrum and fluorescence emission spectrum change not quite in different solvents.
1.5 target compounds are as fluorescent pigment application in coating
Respectively potassium dihydrogen phosphate, dipotassium hydrogen phosphate, dodecylbenzene sodium sulfonate, fatty alcohol-polyoxyethylene ether and Ammonium persulfate. are configured to 10% aqueous solution standby;
Pre-emulsification tank adds 60g dodecylbenzene sodium sulfonate solution, 60g fatty alcohol-polyoxyethylene ether solution, 20g potassium dihydrogen phosphate, 20g dipotassium hydrogen phosphate solution and 200g deionized water, make pre-emulsification tank constant temperature 10 DEG C, add the vinylidene chloride 300g of cold preservation, butyl acrylate 50g, 2-Propenoic acid, 2-methyl-, isooctyl ester 60g, butyl methacrylate 40g and azo-bis-iso-dimethyl 3g while stirring, stirring 30min, adds 15g ammonium persulfate solution and prepares pre-emulsion;
Add 40g dodecylbenzene sodium sulfonate solution, 40g fatty alcohol-polyoxyethylene ether solution, 15g ammonium persulfate solution, 12g potassium dihydrogen phosphate, 12g dipotassium hydrogen phosphate solution and 300g deionized water and stirring in a kettle. uniform;The logical nitrogen deoxygenation of reactor to control pressure be 0.4MPa, mixing speed is 30~90r/min, the pre-emulsion of 10% in reactor is once added when reaction temperature is 60 DEG C, remaining pre-emulsion at the uniform velocity adds reactor in 4h, by reactor release after insulation 1h, it is warmed up to 70 DEG C~90 DEG C insulation 60min, obtains latex;
By sodium tripolyphosphate 6g, ammonium polyacrylate 2g, defoamer 2g, nano zine oxide 80g, the coating fluorescent pigment 220g of embodiment 1 preparation, zinc phosphate 100g, after adipyl trap 50g, thickening agent 5g, levelling agent 8g and deionized water 500g mixing, sand milling is to fineness less than 40 microns, slurry good for sand milling and latex are pressed the mass mixing of 1:1, stirs and obtain fluorescent paint.
Owing to the Hydrogen Energy on the amide groups in the compounds of this invention can form intermolecular hydrogen bond with the ketonic oxygen on coumarin ring, form structure stable as follows:
Meanwhile, the hydrogen on intramolecule, amide groups also can form hydrogen bond with benzothiazole ring nitrogen in molecule, forms structure stable as follows:
Therefore, after this compound is applied to fluorescent paint, the fluorescence of coating has excellent weather resistance.Because general fluorescent paint is at the sunlight of nature, especially the ultraviolet light in sunlight, can cause the structural deterioration of fluorescent chemicals in fluorescent paint, and the compound of the present invention is because stable circulus can be formed in intermolecular or molecule, is therefore not readily susceptible to the destruction of ultraviolet light.
Embodiment 2
A kind of synthetic method of Diarbarone compounds:
Basic step is with embodiment 1, and difference is in step (2), and chloride reagent adopts thionyl chloride, and solvent is toluene, and reaction temperature is 120 DEG C, and the response time is 12h, and yield is 85.6%;
In step (3), amino-compound is aniline, after reacting 10h, reacts 20h under room temperature at-5 DEG C, and yield is 61.7%.
Embodiment 3
A kind of synthetic method of Diarbarone compounds:
Basic step is with embodiment 1, and difference is in step (2), and chloride reagent adopts triphosgene, and solvent is toluene, and reaction temperature is 80 DEG C, and the response time is 7h, and yield is 81.3%;
In step (3), amino-compound is aniline, after reacting 5h, reacts 10h under room temperature at 10 DEG C, and yield is 48.9%.
Embodiment described above is the one preferably scheme of the present invention, not the present invention is done any pro forma restriction, also has other variant and remodeling under the premise without departing from the technical scheme described in claim.

Claims (7)

1. a Diarbarone compounds, it is characterised in that: its structural formula is as follows:
Described R group is phenyl, substituted-phenyl or pyridine radicals.
2. Diarbarone compounds according to claim 1, it is characterised in that described substituent group is selected from any one in substituents:
3. the preparation method of the Diarbarone compounds described in a claim 1, it is characterised in that: described preparation method carries out as follows:
(1) with salicylide, cyan-acetic ester, 3,4-AHBA for raw material, one pot process 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-carboxylic acid;
(2) 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-carboxylic acid that above-mentioned steps is synthetically derived and chloride reagent carry out acyl chloride reaction and are synthetically derived 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-formyl chloride;
(3) 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-formyl chloride that above-mentioned steps obtains reacts with amino-compound and carries out acylation reaction, is synthetically derived Diarbarone compounds.
4. the preparation method of Diarbarone compounds according to claim 3, it is characterised in that: described chloride reagent is oxalyl chloride, thionyl chloride or triphosgene, and described amino-compound is aniline, replacement, aniline or aminopyridine.
5. the preparation method of Diarbarone compounds according to claim 4, it is characterised in that: described amino-compound is any one in following amino-compound:
6. the preparation method of Diarbarone compounds according to claim 3, it is characterised in that: described preparation method is specific as follows:
(1) in 100mL there-necked flask, salicylide 17mmol, cyan-acetic ester 17mmol, 3,4-AHBA 17mmol, benzoic acid 5.8mmol and n-amyl alcohol 50mL it are sequentially added into, it is heated to reflux 5-12h, it is cooled to room temperature, reactant liquor is poured in 100mL water, precipitate out a large amount of precipitation, sucking filtration, washes with water dried, obtains orange solids 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-carboxylic acid;
(2) in 50mL there-necked flask, 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-carboxylic acid 1mmol and solvent 30mL is added, chloride reagent 1.2mmol is dripped under room temperature, add DMF1 and drip as catalyst, solvent and residue chloride reagent are evaporated off after reacting 2-10h at 20-120 DEG C, obtaining khaki solid 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-formyl chloride, described solvent is dichloromethane or toluene;
(3) in 100mL there-necked flask, it is sequentially added into amino-compound 1mmol, Na2CO31.1mmol and anhydrous CH2Cl220mL, is cooled to 0~5 DEG C, drips 2-(2-carbonyl-2H-1-.alpha.-5:6-benzopyran-3-base) benzothiazole-5-formyl chloride 1mmol and anhydrous CH2Cl2The mixed liquor of 30mL, after reacting 3-106h in-5~10 DEG C, reacts 5-20h, filters under room temperature, filtrate adds saturated NaHCO3Solution 25mL, stratification, the anhydrous CH of water layer2Cl2Extracting, merge organic facies, solvent is evaporated off, column chromatography purifies, and the volume ratio=4:1 of developing solvent petroleum ether and ethyl acetate obtains Diarbarone compounds.
7. the application of the Diarbarone compounds described in a claim 1-6 any one, it is characterised in that: as fluorescent pigment application in coating.
CN201610178931.XA 2016-05-31 2016-05-31 Coumarin amides compound as well as preparation method and application of coumarin amides compound Pending CN105777729A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610178931.XA CN105777729A (en) 2016-05-31 2016-05-31 Coumarin amides compound as well as preparation method and application of coumarin amides compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610178931.XA CN105777729A (en) 2016-05-31 2016-05-31 Coumarin amides compound as well as preparation method and application of coumarin amides compound

Publications (1)

Publication Number Publication Date
CN105777729A true CN105777729A (en) 2016-07-20

Family

ID=56391020

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610178931.XA Pending CN105777729A (en) 2016-05-31 2016-05-31 Coumarin amides compound as well as preparation method and application of coumarin amides compound

Country Status (1)

Country Link
CN (1) CN105777729A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108752327A (en) * 2018-04-17 2018-11-06 浙江工业大学 3- (2- benzoxazoles) Diarbarone compound and its preparation method and application

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404389A (en) * 1978-02-23 1983-09-13 Basf Aktiengesellschaft Thiazole containing coumarin compounds
CN1168686A (en) * 1994-12-07 1997-12-24 巴斯福股份公司 Benzopyran dyes and their intermediates
CN1258698A (en) * 2000-01-21 2000-07-05 大连理工大学 Fluorescent coumarin dye
CN1594441A (en) * 2004-06-17 2005-03-16 上海交通大学 Fluorescent coumarin dye
CN101368004A (en) * 2008-09-25 2009-02-18 浙江工业大学 Synthesis of coumarin fluorochromes
CN103172626A (en) * 2011-12-26 2013-06-26 住友化学株式会社 Dye compound
CN103319475A (en) * 2013-02-01 2013-09-25 山西大同大学 N'-benzothiazolyl-3-formamido-7-(N, N-diethyl)coumarin, and preparation method and applications thereof
CN103360377A (en) * 2012-03-29 2013-10-23 住友化学株式会社 A compound used for a dye

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404389A (en) * 1978-02-23 1983-09-13 Basf Aktiengesellschaft Thiazole containing coumarin compounds
CN1168686A (en) * 1994-12-07 1997-12-24 巴斯福股份公司 Benzopyran dyes and their intermediates
CN1258698A (en) * 2000-01-21 2000-07-05 大连理工大学 Fluorescent coumarin dye
CN1594441A (en) * 2004-06-17 2005-03-16 上海交通大学 Fluorescent coumarin dye
CN101368004A (en) * 2008-09-25 2009-02-18 浙江工业大学 Synthesis of coumarin fluorochromes
CN103172626A (en) * 2011-12-26 2013-06-26 住友化学株式会社 Dye compound
CN103360377A (en) * 2012-03-29 2013-10-23 住友化学株式会社 A compound used for a dye
CN103319475A (en) * 2013-02-01 2013-09-25 山西大同大学 N'-benzothiazolyl-3-formamido-7-(N, N-diethyl)coumarin, and preparation method and applications thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ALAA S. ABD-EL-AZIZ ET AL.: "Synthesis of Novel Coumarin and Benzocoumarin Derivatives and their Biological and Photophysical Studies", 《J. HETEROCYCLIC CHEM.》 *
贾建洪: "新型有机荧光溶剂染料及中间体的合成研究", 《中国优秀硕士学位论文全文数据库(电子期刊)工程科技Ⅰ辑》 *
陈庆锋 等: "新型香豆素染料的合成及荧光性能研究", 《浙江工业大学学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108752327A (en) * 2018-04-17 2018-11-06 浙江工业大学 3- (2- benzoxazoles) Diarbarone compound and its preparation method and application
CN108752327B (en) * 2018-04-17 2020-11-13 浙江工业大学 3- (2-benzoxazole) coumarin amide compound and preparation method and application thereof

Similar Documents

Publication Publication Date Title
Li et al. Tetrahydro [5] helicene-based full-color emission dyes in both solution and solid states: Synthesis, structures, photophysical properties and optical waveguide applications
Wang et al. Rational design of novel near-infrared fluorescent DCM derivatives and their application in bioimaging
CN105462576A (en) Near infrared BODIPY fluorescence dye and preparation method thereof
CN113896677B (en) Reversible electrochromic material with aggregation-induced emission property and preparation method thereof
CN102965099B (en) Novel rare earth/terpyridyl functionalized ionic liquid luminescent material
CN109608644A (en) Imide derivative and preparation method and purposes as fluorine ion fluorescence probe
Zhou et al. D–A type luminophores with a twisted molecular conformation constructed by phenoxazine and diphenylsulfone showing high contrast mechanofluorochromism
CN110407832A (en) A kind of Anthraquinones electroluminescent organic material and its application
CN109438459A (en) A kind of organic second order non-linear optical chromophore and its synthetic method and application
CN104356055B (en) A kind of dihydrogen pyridine derivatives and synthetic method thereof and purposes
CN107382982A (en) Dicyano methylene 4H pyran derivates and preparation method thereof and purposes
CN110117235B (en) Compound with aggregation-induced light emission and mechanochromism characteristics and preparation method and application thereof
CN107759504B (en) Dual-phase organic fluorescent material with strong fluorescence in solid and liquid states and preparation method thereof
CN105777729A (en) Coumarin amides compound as well as preparation method and application of coumarin amides compound
CN115819281B (en) Cyano-substituted p-phenylene ethylene derivative, preparation method and application
CN101942210B (en) 4-amido-1,8-naphthalimide derivative fluorescent dichroic dye and application thereof
CN116874747A (en) Electrochromic polymer, preparation method thereof and electrochromic polymer film
CN106188067A (en) Diketopyrrolopyrrolederivative derivative and perovskite battery thereof
CN106810898B (en) Organic dye sensitized dose of the triphen amine of pyrroles's dithione modification and its application
CN105038294A (en) Indole-triphenylamine-arylmethylidenemalononitrile solar energy co-sensitization dye, synthetic method and application thereof
CN105968130B (en) Two pyrroles's methine derivatives and preparation method thereof are complexed containing double center boron fluorides of carbazole and bridge linkage group in a kind of middle position
CN107602456B (en) Azopyridine salt compound and preparation method thereof
CN102942568A (en) 2-[(N- alkyl carbazolyl) vinyl]-1, 8-naphthyridine derivative as well as preparation method and application thereof
CN111423450A (en) Compound, display panel and display device
CN109320459A (en) A kind of phenanthro- imidazole derivative containing fluorenes, crystal and the preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160720

RJ01 Rejection of invention patent application after publication